[en] Breast cancer metastasizes to bone more frequently than to any other organ, and over 80% of advanced breast cancer patients develop bone metastases. Our recent demonstration that human breast cancer cells express bone sialoprotein (BSP), a bone matrix protein, provides a possible clue for the selective affinity of breast cancer cells for bone. We tested the hypothesis that detection of BSP in primary human breast cancer could be a potential indicator of the ability of breast cancer cells to metastasize to bone. BSP expression was evaluated in the primary breast cancers of 39 patients using immunoperoxidase and two specific anti-BSP antibodies. None of these patients presented clinically or scintigraphically detectable bone metastases at the time of surgery. In the course of their disease, 22 patients developed clinically diagnosed bone metastases. Expression of BSP in breast cancer cells from patients who developed bone metastases was significantly higher (p = 0.008, according to the Mann-Whitney test) than in patients with no bone involvement. No association was found between BSP expression in the primary breast lesions and axillary lymph node metastases. BSP expression was significantly increased in infiltrating ductal carcinoma compared with infiltrating lobular carcinoma (p = 0.0023). No correlation was found between immunoreactivity to BSP antibodies and estrogen receptor (ER) status, progesterone receptor (PR) status, or age. Our data suggest that BSP could help to identity which women will develop bone metastases and provide new bases for the understanding of the molecular mechanism(s) responsible for breast cancer cells osteotropism.
Bellahcene, Akeila ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Labo de recherche sur les métastases
Kroll, M.
Liebens, F.
Castronovo, Vincenzo ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie générale et cellulaire
Language :
English
Title :
Bone Sialoprotein Expression in Primary Human Breast Cancer Is Associated with Bone Metastases Development
Publication date :
May 1996
Journal title :
Journal of Bone and Mineral Research
ISSN :
0884-0431
eISSN :
1523-4681
Publisher :
Wiley-Blackwell, Washington, United States - District of Columbia
Volume :
11
Issue :
5
Pages :
665-70
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
Fondation contre le Cancer [BE] Association Sportive Contre le Cancer European Community program BIOMED 1 F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE]
Haagensen CD 1974 The choice of treatment for operable carcinoma of the breast. Surgery 76:685-714.
Sklaroff DM, Charkes ND 1968 Bone metastases from breast cancer at the time of radical mastectomy. Surg Gynecol Obstet 127:763-768.
Hoffman HC, Marry R 1972 Bone scanning. Its value in the preoperative evaluation of patients with suspicious breast masses. Am J Surg 124:194-199.
Galasko CSB 1969 The detection of skeletal metastases from mammary cancer by gamma camera scintigraphy. Br J Surg 56:757-764.
Bellahcène A, Merville M-P, Castronovo V 1994 Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Res 54:2823-2826.
Bellahcène A, Castronovo V 1995 Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am J Pathol 146:1-6.
Fisher LW, Termine JD 1985 Noncollagenous proteins influencing the local mechanisms of calcification. Clin Orthopaed Rel Res 200:362-385.
Oldberg A, Franzen A, Heinegard D 1988 The primary structure of a cell-binding bone sialoprotein. J Bioi Chem 263: 19430-19432.
Fisher LW, McBride W, Termine JD, Young MF 1990 Human bone sialoprotein: deduced protein sequence and chromosomal localization. J Biol Chem 265:2347-2351.
Bianco P, Fisher LW, Young MF, Termine JD, Robey PG 1991 Expression of bone sialoprotein (BSP) in developing human tissues. Calcif Tissue Int 49:421-426.
Oldberg A, Franzen A, Heinegard D, Pierschbacher M, Ruoslahti E 1988 Identification of a bone sialoprotein receptor in osteosarcoma cells. J Biol Chem 263:19433-19436.
van der Pluijm G, Kerr J, Lowik C, Gehron Robey P 1993 β1 and β3 integrin subunits are involved in adhesion of breast cancer cells to extracellular bone matrix. J Bone Miner Res 8(Suppl 1):S136 (abstract).
McGuire W, De La Garza M 1973 Improved sensitivity in the measurement of oestrogen receptor in human breast cancer. J Clin Endocrinol Metab 37:986-989.
Mintz KP, Grzesik WJ, Midura RJ, Gehron Robey P, Termine JD, Fisher LW 1993 Purification and fragmentation of nondenaturated bone sialoprotein: evidence for a cryptic, RGD-resistant cell attachment domain. J Bone Miner Res 8:985-995.
Fisher LW, Hawkins GR, Tuross N, Termine JD 1987 Purification and partial characterization of small proteoglycans I and 11, bone sialoproteins I and II, and osteonectin from the min-eral compartment of developing human bone. J Biol Chem 262:9702-9708.
Chen J, Shapiro SS, Wrana JL, Reimers S, Heersche JNM, Sodek J 1991 Localization of bone sialoprotein (BSP) expression to sites of mineralized tissue formation in fetal rat tissues by In situ hybridization. Matrix 11:133-143.
Walther H 1948 Krebsmetastasen. B.s. Verlag, Basel, Switzerland.
Ross F, Chappel J, Alvarez J, Sander D, Butler W, Farash-Carson M, Mintz K, Gehron Robey P, Teitelbaum S, Cheresh D 1993 Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin αvβ3 potentiate bone resorption. J Biol Chem 268:9901-9907.
van der Pluijm G, Ivanov B, Robey F, Gehron Robey P, Papapoulos S, Löwik C 1995 Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone in vitro. J Bone Miner Res 10(Suppl 1):S177 (abstract).
Manishen WJ, Sivananthan K, Orr FW 1986 Resorbing bone stimulates tumor cell growth. A role for the host microenvironment in bone metastasis. Am J Pathol 123:39-45.
Eilon G, Mundy GR 1978 Direct resorption of bone by human breast cancer cells in vitro. Nature 276:726-728.